Xenon Pharmaceuticals Inc (XENE) short volume · rev $7.5M
Xenon Pharmaceuticals Inc FINRA short-volume cache. Latest 2026-10-21.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-10-21 | 229,781 | 346,169 | 66.4% |
| 2026-10-20 | 180,140 | 379,198 | 47.5% |
| 2026-10-19 | 372,322 | 534,770 | 69.6% |
| 2026-10-16 | 311,591 | 453,849 | 68.7% |
| 2026-10-15 | 394,798 | 629,864 | 62.7% |
| 2026-10-14 | 226,927 | 471,084 | 48.2% |
| 2026-10-13 | 281,661 | 418,557 | 67.3% |
| 2026-10-12 | 142,128 | 229,733 | 61.9% |
| 2026-10-09 | 168,042 | 374,341 | 44.9% |
| 2026-10-08 | 469,248 | 908,292 | 51.7% |
XENE short volume FAQ
What was XENE's latest FINRA short volume?
On Oct 21, 2026, cached FINRA short volume for Xenon Pharmaceuticals Inc (XENE) was 229,781 shares, 66.4% of 346,169 total volume.
How many XENE short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Xenon Pharmaceuticals Inc (XENE), from Oct 8, 2026 through Oct 21, 2026.
How did XENE short volume percent change from the prior cached session?
Cached FINRA short volume for Xenon Pharmaceuticals Inc (XENE) moved from 47.5% on Oct 20, 2026 to 66.4% on Oct 21, 2026, up 18.9 percentage points.
What was the highest XENE short volume percent on this page?
The highest cached FINRA short volume on this page is 69.6% of total volume on Oct 19, 2026.
What is XENE's latest revenue?
Latest cached Xenon Pharmaceuticals Inc (XENE) revenue for Dec 31, 2025 was $7.5M. Statements: https://lician.com/financials/xene
What is the average XENE short volume percent on this page?
Across 10 cached sessions on this page, Xenon Pharmaceuticals Inc (XENE) short volume averaged 58.9% of total volume.
Where is XENE short volume listed?
Cached FINRA short volume for Xenon Pharmaceuticals Inc (XENE) is listed at https://lician.com/short-interest/xene.
Not investment advice. Cached rows, not a live tape.